Cargando…
A Survey of Industry Perceptions of Facilitated Regulatory Pathways in Drug Development in Australia
BACKGROUND: In Australia, facilitated regulatory pathways (FRPs) became available with the introduction of priority review (PR) in 2017 and provisional approval (PA) in 2018, which aim to facilitate expedited review and approval for novel medicines. The pathways were developed in consultation with a...
Autores principales: | Yoffe, Alina, Liu, Johnson, Smith, Greg, Chisholm, Orin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460712/ https://www.ncbi.nlm.nih.gov/pubmed/37368166 http://dx.doi.org/10.1007/s40290-023-00483-x |
Ejemplares similares
-
Regulatory Reform Outcomes and Accelerated Regulatory Pathways for New Prescription Medicines in Australia
por: Yoffe, Alina, et al.
Publicado: (2022) -
Future directions in regulatory affairs
por: Chisholm, Orin, et al.
Publicado: (2023) -
Multi-Criteria Decision Analysis for Benefit-Risk Analysis by National Regulatory Authorities
por: Chisholm, Orin, et al.
Publicado: (2022) -
Industrial perceptions of medicines regulatory harmonization in the East African Community
por: Dansie, Live Storehagen, et al.
Publicado: (2019) -
FDA Facilitated Regulatory Pathways: Visualizing Their Characteristics, Development, and Authorization Timelines
por: Liberti, Lawrence, et al.
Publicado: (2017)